Search For "oral rna dependent rna polymerase inhibitor"
Recently published data on Favipiravir as treatment for mild to mo
Updated : 3 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], November 23 (ANI/PRNewswire): The oral antiviral medication Favipiravir, that prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with mild to moderate COVID-19.
Read More